FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Composition |
| Id | Composition-568069.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
[No data.]
{
"resourceType": "Composition",
"id": "568069",
"meta": {
"versionId": "7",
"lastUpdated": "2026-07-23T15:43:15.394Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/m11-report-section-12"
]
},
"text": {
"status": "empty",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-description",
"valueMarkdown": "Example of M11ReportSection12 Profile"
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/Composition/568069",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "568069",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"status": "final",
"type": {
"coding": [
{
"system": "http://loinc.org",
"code": "35528-9",
"display": "Clinical trial protocol Clinical trial protocol"
}
],
"text": "CeSHarP Report"
},
"category": [
{
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218666",
"display": "ICH M11 Protocol Section 12 APPENDIX: SUPPORTING DETAILS"
}
],
"text": "section12-supporting-details"
}
],
"subject": [
{
"reference": "ResearchStudy/267245",
"type": "ResearchStudy",
"display": "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"
}
],
"date": "2026-07-23T15:43:15.394Z",
"author": [
{
"display": "Brian S. Alper, MD, MSPH"
}
],
"title": "M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example",
"custodian": {
"reference": "Organization/118079",
"type": "Organization",
"display": "Computable Publishing LLC"
},
"relatesTo": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type",
"code": "derived-from",
"display": "Derived from"
}
]
},
"targetReference": {
"reference": "ResearchStudy/267245",
"type": "ResearchStudy",
"display": "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"
}
},
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type",
"code": "cite-as",
"display": "Cite As"
}
]
},
"targetMarkdown": "M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568069. Revised 2026-07-23. Available at: https://fevir.net/resources/Composition/568069. Computable resource at: https://fevir.net/resources/Composition/568069#json."
}
],
"section": [
{
"title": "12 APPENDIX: SUPPORTING DETAILS",
"code": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218666",
"display": "ICH M11 Protocol Section 12 APPENDIX: SUPPORTING DETAILS"
}
],
"text": "section12-supporting-details"
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">[No text is intended here (heading only).]</div>"
},
"section": [
{
"title": "12.1 Clinical Laboratory Tests",
"code": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218667",
"display": "ICH M11 Protocol Section 12.1 Clinical Laboratory Tests"
}
],
"text": "section12.1-clinical-laboratory-tests"
},
"text": {
"status": "additional",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7 pages of images replaced with this statement.</p></div>"
}
},
{
"title": "12.2 Country/Region-Specific Differences",
"code": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218668",
"display": "ICH M11 Protocol Section 12.2 Country/Region-Specific Differences"
}
],
"text": "section12.2-country-specific-differences"
},
"text": {
"status": "additional",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Not applicable.</p></div>"
}
},
{
"title": "12.3 Prior Protocol Amendment(s)",
"code": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C218669",
"display": "ICH M11 Protocol Section 12.3 Prior Protocol Amendment(s)"
}
],
"text": "section12.3-prior-protocol-amendments"
},
"text": {
"status": "additional",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Not applicable. This is the first protocol amendment.</p></div>"
}
}
]
}
]
}